When grouping by 1-year vital status, patients in the non-survival group were older; had more comorbidities (hypertension, peripheral artery disease, AF, and CKD); were more likely to have a previous history of MI and stroke; and had lower Hb, lymphocyte counts, and Alb. This evidence concerns the gene GSTM1 and peripheral arterial disease.